Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis treatment for Alexander disease granted orphan drug status from EMA

CARLSBAD, Calif. , Feb. 11, 2020 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the European Medicines Agency (EMA) has granted orphan drug designation to ION373 for the treatment of people with Alexander disease, a severe,